第 1 到 2 筆結果,共 2 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis | HSIANG-FONG KAO ; HUAI-CHENG HUANG ; BIN-CHI LIAO ; RUEY-LONG HONG | BMC cancer | 2 | 2 | |
2 | 2022 | Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis | HSIANG-FONG KAO ; BIN-CHI LIAO ; YEN-LIN HUANG ; HUAI-CHENG HUANG ; Chun-Nan Chen ; TSENG-CHENG CHEN ; Hong, Yuan Jing; Chan, Ching Yi; JEAN-SAN CHIA ; RUEY-LONG HONG | Clinical Cancer Research | 35 | 28 |